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Contributions to neuroscience are necessary to understand the behavior of the brain. 1 
This requires using powerful analytical techniques to monitor neuroactive molecules and 2 
their concentrations in biological samples (fluids, cells, and brain tissues). Capillary 3 
Electrophoresis (CE) is well known for its high resolution power, short analysis times, 4 
and low consumption of reagents and samples. It presents analytical advantages for the 5 
determination of neuroactive molecules not easy determined by other analytical 6 
techniques. CE also offers the possibility of controlling more than one neuroactive 7 
molecule at a time which is interesting to detect changes as a result of a stimulus. CE is 8 
well-established to accomplish enantioseparations, contributing with a better 9 
understanding of the properties of a neuroactive chiral molecule. This review is focused 10 
on the most relevant articles published from January 2008 to July 2014, based on the 11 
determination in biological samples of potentially interesting molecules in neuroscience 12 
using CE and microchip-CE.  13 
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3-MT: 3-methoxytyramine; 5-HIAA: 5-hydroxyindole-3-acetic acid; 5-HT: serotonin; µ-19 
TAS: micro-total analysis system; ABEI: N-(4-aminobutyl)-N-ethylisoluminol; ACh: 20 
acetylcholine; AD: amperometric detection ; Ala: alanine; Arg: arginine; Asn: asparagine; 21 
Asp: aspartate; BGE: background electrolyte; BPA: bisphenol A; Br-BQCA: 3-(4-22 
bromobenzoyl)-2-quinolinecarboxaldehyde; CD: cyclodextrin; CEC: Capillary Electro-23 
Chromatography; C4D: capacitive coupled contactless conductivity detection; CE: 24 
Capillary Electrophoresis; CFSE: 5-carboxyfluorescein N-succinimidyl ester; Cit: 25 
citruline; CL: chemiluminiscence; CNS: central nervous system; CSF: cerebrospinal 26 
fluid; CSP: chiral stationary phase; Cys: cysteine; CZE: Capillary Zone Electrophoresis; 27 
DA: dopamine; DM-β-CD: dimethyl-β-CD; DOPA: 3,4-dihydroxyphenylalanine; 28 
DOPAC, 3,4-dihydroxyphenylaceticacid; DTAF: 5-(4,6-dichloro-s-triazin-2-ylamino) 29 
fluorescein; EC: electrochemical; EKC: Electrokinetic Chromatography; EP: 30 
epinephrine; FASS: field-amplified sample stacking; FITC: fluorescein isothiocyanate; 31 
FSCV: fast-scan cyclic voltammetry ; GABA: γ-aminobutyric acid; Gln: glutamine; Glu: 32 
glutamate; Gly: glycine; Him: histamine; His: histidine; HPA-β-CD: 6-monodeoxy-6-33 
mono(3-hydroxy)-propylamino-β-cyclodextrin; HPLC: High Performance Liquid 34 
Chromatography; HP-β-CD: hydroxypropyl-β-CD; HVA: homovanillic acid; Ile: 35 
isoleucine; IT: ion trap; IXS: 3-indoxyl sulfate; LED: light-emitting electrodes; Leu: 36 
leucine; LIF: laser-induced fluorescence; LINF: laser-induced native fluorescence; 37 
LVSS: large volume sample stacking; Lys: lysine; MCE: microchip capillary 38 
electrophoresis; Met: methionine; MEKC: Micellar Electrokinetic Chromatography; 39 
MEEKC: Micro-Emulsion Electrokinetic Chromatography; MIP: molecular imprinted 40 
polymer; MISPE: molecular imprinted solid phase extraction; MMIP: magnetic 41 
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molecular imprinted polymer; NBD-F: 7-nitrobenzo-2-oxa-1,3-diazole; NDA: 42 
naphthalene-2,3-dicarboxyaldehyde; NE: norepinephrine; NM: normetanephrine; OP: 43 
octopamine; OPA: o-phthalaldehyde; Orn: ornithine; PBS: phosphate buffer saline; 44 
PDDAC: poly(diallyldimethylammonium) chloride; PDMS: polydimethylsiloxane; Phe: 45 
phenylalanine; Pro: proline; Q: quadrupole; SDS: sodium dodecilsulfate; Ser: serine; 46 
SPE: solid phase extraction; SPME: solid phase micro-extraction; TA: tryptamine; Tau: 47 
taurine; TCA: trichloroacetic acid; Thr: threonine; TOF: time-of-flight; Trp: tryptophan; 48 
Tym: tyramine; Tyr: tyrosine; Val: valine; VMA: vanillomandelic acid.  49 
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1. Introduction 64 
Neuroscience, the study of the nervous system, has been increasingly investigated 65 
over the last century. Neurons play the most important role in the nervous system since 66 
they are the cells in charge to transmit the information by electrical and chemical signals. 67 
Signal transmission can be driven by chemical messengers, also known as neuroactive 68 
compounds (neurotransmitters and/or neuromodulators), which are involved in plenty of 69 
signal transmissions occurring in the neuron’s synapse. In this synapse, the neuroactive 70 
compounds are released to bind to the receptors in the membrane of a target cell [1]. 71 
Neurotransmission has been proven to be related to the behavioral, cognitive, and 72 
emotional state of an organism and also to be associated to conditions such as depression, 73 
drug dependence, schizophrenia, and degenerative diseases [2]. Most of the Central 74 
Nervous System (CNS) diseases are caused and can be accentuated by complex and 75 
abnormal disturbances or disruptions of regulatory mechanisms, protein expression 76 
profiles or in some metabolic pathways [3].  77 
A large variety of molecules can be neurologically active ranging from gases as 78 
nitric oxide, carbon monoxide and hydrogen sulfide, to small molecules such as amino 79 
acids (both protein and non-protein) and biogenic amines (monoamines, histamine and 80 
acetylcholine), and to larger molecules as neuropeptides or hormones [1, 4]. Glycine 81 
(Gly), taurine (Tau) and γ-aminobutyric acid (GABA) are the main inhibitory amino acids 82 
[2], on the contrary to glutamate (Glu) and aspartate (Asp) which are the most widespread 83 
excitatory neuroactive compounds in the CNS and influence numerous neuronal networks 84 
[1]. Serotonin (5-HT), a monoamine derived from tryptophan (Trp), is implied in 85 
physiological functions such as memory, learning, feeding, sleep and body temperature 86 
regulation and it is also involved in pathologies such as depression, Alzheimer’s disease, 87 
autism, schizophrenia, and bipolar disorder [1]. Other monoamines such as the 88 
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catecholamines dopamine (DA), epinephrine (EP), and norepinephrine (NE), all derived 89 
from tyrosine (Tyr) and phenylalanine (Phe), are other important molecules in 90 
neurotransmission. These catecholamines play an important role in the diagnosis of many 91 
disorders such as Alzheimer’s [5] and Parkinson’s diseases [6], cocaine addiction, 92 
pheochromocytoma and a variety of mental diseases [7]. Other important neuroactive 93 
molecules are the biogenic amines histamine (Him), which is involved in a high variety 94 
of physiological responses (the regulation of sleep, the secretion of hormones, and the 95 
formation of cognition) [8, 9]; and acetylcholine (ACh), which was the first neuroactive 96 
molecule discovered and it is known that dysfunction in the cholinergic system is related 97 
with Alzheimer’s and Parkinson’s diseases [1]. 98 
The potential role of D-amino acids in aging and neurodegenerative processes such 99 
as Alzheimer’s disease was revealed years ago by Fisher and D’Aniello [10, 11] and this 100 
role has been studied ever since [12]. D-serine (D-Ser), D-alanine (D-Ala), and D-Asp 101 
have all been found in relatively significant levels in the CNS [13]. D-Ser plays an 102 
important role in neuroplasticity, memory, and learning [12], and the amounts of D-Ser 103 
and D-Ala in mammals have been related with schizophrenia and depression [13, 14]. D-104 
Asp has been related with some neuromodulator functions and it is involved in 105 
developmental and endocrine functions [12]. In the case of catecholamines, it is known 106 
that interaction of L/D-EP and L/D-NE with their receptors is stereoselective, exhibiting 107 
their enantiomers different activity and selectivity [15], although no clear relation 108 
between neurotransmission function and enantiomers has been established yet. 109 
The above-mentioned information points out the importance of the development of 110 
analytical tools to determine these small molecules to study neurological disorders to 111 
measure and evaluate the progress of a disease or a process that occurs in the CNS, and/or 112 
to find the possible response to a specific treatment [3]. As well, multiple analyte 113 
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detection is an attractive characteristic from the point of view of neuroscience due to the 114 
fact that the alteration of more than one neuroactive substance at a time can be studied as 115 
a result of a stimulus. Thus, analytical techniques frequently employed for monitoring 116 
neuroactive molecules are related to rapid, sensitive, and efficient analysis, and should 117 
offer the possibility to perform it in samples with significantly low volumes (some of 118 
them just few microliters) and with concentrations of the compounds of interest very low 119 
(sometimes even below the nM level).  120 
Some review articles [4, 16] have been focused on the application of different 121 
analytical techniques for neuroactive compounds determination being High Performance 122 
Liquid Chromatography (HPLC), and Capillary Electrophoresis (CE), or enzyme assays 123 
and biosensors microelectrodes, the most widely used approaches. Among all these 124 
techniques, CE can be considered as a suitable and reliable technique to study potentially 125 
interesting molecules in neuroscience because of its high resolution power, fast-analysis 126 
and the use of small sample volumes (nanoliters or even less) what makes it ideal for in 127 
vitro or in vivo analysis of neurological samples. Moreover, as described before, chiral 128 
analysis represents a promising topic in neuroactive compounds determination because 129 
of the differences in the biological activities of a pair of enantiomers. Therefore, an 130 
analytical technique capable of resolving enantiomers should facilitate the understanding 131 
of the activity of the enantiomeric neuroactive compounds. In this aspect, CE is 132 
considered as one of the most powerful and useful techniques in chiral separations due to 133 
its wide possibilities [17, 18]. 134 
Contributions of CE to neuroscience have been summarized in different review 135 
articles [2, 19].Taking into account that different works have been published afterwards, 136 
our aim is to cover recent articles, published from January 2008 to July 2014, looking at 137 
the review published in 2008 as a starting point. To the best of our knowledge, all relevant 138 
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articles published within the mentioned period of time which were focused on the 139 
determination by CE and microchip CE of neuroactive compounds in biological samples 140 
of interest in neuroscience have been considered. Our work sorts the CE methods by the 141 
detector system employed highlighting the differences among them and indicating the 142 
instrumentation needed. As a consequence, methods with different detection systems can 143 
be easily followed and compared. We also discuss the importance and possibilities of the 144 
sample preparation, pre-concentration techniques, and chirality in the determination of 145 
potentially interesting molecules in neuroscience, whose contributions have been 146 
increasing since 2008. 147 
 148 
2. Capillary Electrophoresis for the determination of neuroactive compounds 149 
 150 
2.1. Sample preparation  151 
Analysis of biological samples provides very useful information when studying 152 
neuroactive molecules of interest in neuroscience research. The most widely analyzed 153 
samples are different biological fluids, cells, and brain tissues. Biological fluids such as 154 
urine, blood (plasma, serum, and whole blood), cerebrospinal fluid (CSF), and 155 
extracellular fluid (ECF) of certain regions of the brain are the fluids analyzed to 156 
determine neuroactive molecules. For instance, determination of catecholamines in urine 157 
is a well-known tool in the diagnosis of pheochromocytoma [20], plasma levels of 158 
neuroactive amino acids can be used in the diagnosis of several disorders as bipolar 159 
disorder [21], CSF is very useful in the diagnosis of Alzheimer’s disease [22], and ECF 160 
can be useful to study the effects in the brain during ischemia and reperfusion periods 161 
[23]. The analysis of single mammalian cells such as PC-12 nerve cells [24] or nerve cells 162 
from invertebrates as the sea slug Aplysia californica [25] is carried out to increase the 163 
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knowledge regarding the CNS behavior. Finally, analysis of certain regions of the brain 164 
(white matter, gray matter, frontal cortex, hippocampus, parietal, temporal cortex, 165 
amygdale, or cerebellum) can be useful for the determination of neuroactive molecules. 166 
In this aspect, analysis of brain tissue provides useful information regarding 167 
neurodegenerative diseases, such as Alzheimer’s [26].  168 
The nature of these biological samples require a cleanup step or a procedure to 169 
extract or isolate neuroactive molecules. Hence, in order to ensure the adequate 170 
determination of the compounds of interest, a reliable sample treatment is of great 171 
importance. The treatment of all biological fluids is usually very similar, this consisting 172 
of the elimination of interfering proteins by precipitation (with solvents as acetonitrile, or 173 
acids as trichloroacetic and perchloric), followed by a centrifugation step and finally a 174 
filtration of the supernatant, or directly by ultrafiltration with cut-off membranes. From 175 
the two procedures, ultrafiltration has the advantage of, not only being simpler and faster, 176 
but also enables working with smaller sample volumes and reducing sample dilution. 177 
However, the high cost of these cut-off membranes is the main drawback of this 178 
procedure. In the case of urine analysis, desalting procedures with liquid-liquid extraction 179 
and solid phase extraction (SPE) have also been reported.  180 
SPE can be considered as an interesting technique for selective sample preparation 181 
and purification prior CE analysis of liquid biological samples. Additionally, molecular 182 
imprinted polymers (MIPs) have been applied as sorbents in several SPE cartridges for 183 
being high selective to the template molecules and for their easy preparation and long 184 
lifetime. This technique is known as molecularly imprinted solid-phase extraction 185 
(MISPE). Related procedures include MIP with solid phase micro-extraction (SPME) and 186 
magnetic molecular imprinted polymer (MMIP) with SPE.  187 
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Regarding cell analysis, a sample treatment based on washing with phosphate 188 
buffer saline (PBS) solution, cell lysis by sonication, and elimination of interfering 189 
proteins as described above are the most common procedures [27].  190 
Finally, the main sample treatment used in the analysis of brain tissue is its 191 
homogenization in a solution (buffer, EDTA, or acids such as formic, ascorbic or 192 
perchloric) with or without sonication, and subsequent removal of proteins as described 193 
above [26]. Freeze-drying is a novel sample preparation technique in which the sample is 194 
frozen and dehydrated under reduced pressure, forcing the water within the sample to 195 
sublimate directly into the gas phase. Berglund et al. [28] demonstrated that freeze-drying 196 
is a faster process in sample preparation in comparison with a conventional dissection, 197 
which allowed concentrating the sample by increasing the number of brains in a fixed 198 
homogenate volume. As a complementary sampling, microdialysis offers the possibility 199 
to analyze ECF in order to perform the in vivo determination of neuroactive molecules 200 
present in certain regions of the brain. The microdialysis involves implanting a small 201 
probe containing a semipermeable membrane that will allow molecules from a specific 202 
tissue to diffuse across [29]. Thus, tiny volumes containing only small molecules will be 203 
trapped and collected for a perfectly suitable analysis by CE [30]. When dialysate samples 204 
are used, generally no other sample treatments are used. 205 
Note that it is also possible to couple the microdialysis sampling on-line to CE 206 
which will potentially increase the sampling frequency allowing to monitor rapid changes 207 
correlated with behavioral episodes or after a stimulus [31, 32]. Thus, the in vivo 208 
monitoring in rat brain tissues by on-line microdialysis of several amino acids (Asp, 209 
GABA, Glu, Gly, Ser, and Tau), important neuroactive compounds, enabled to observe 210 
changes in their levels after ethanol self-administration [31] or depending on the sleep 211 
stage [32]. In this last work authors pointed out the importance of on-line microdialysis 212 
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to measure these neuroactive compounds in the sleep episodes of the rodents (during non-213 
rapid eye movement sleep and rapid eye movement sleep), since they are relatively short.  214 
 215 
2.2. CE with UV absorption detection  216 
Many works have been described employing UV absorption detection in the 217 
determination of neuroactive and related compounds (see Table 1). Amino acids, 218 
catecholamines, and other biogenic amines in urine samples have been the most studied 219 
compounds. Capillary Zone Electrophoresis (CZE) has been the CE mode employed in 220 
all works except in one of them which employed Capillary Electro-Chromatography 221 
(CEC) to carry out a chiral separation. LODs in the nanomolar range (between 2·10-9 M 222 
and 300·10-9 M) have been achieved usually employing low UV wavelengths (< 220 nm) 223 
and mostly used in-capillary sampling pre-concentration techniques during sample 224 
injection. It is worth highlighting that in most of the cases the determined concentration 225 
of these analytes was above the LOD [33-35, 37, 39, 41, 42], whereas in other works 226 
spiking of the samples had to be performed [36, 38-40]. 227 
Simultaneous separation of catecholamines, indolamines and metanephrines in 228 
urine sample from a healthy volunteer has been reported using an in-capillary sample pre-229 
concentration technique [33]. Based on the different mobility of the analytes in presence 230 
and in absence of poly(diallyldimethylammonium) chloride (PDDAC) in the background 231 
electrolyte (BGE), analytes could be easily stacked between the boundary of the sample 232 
zone and the BGE containing PDDAC due to a raise in the viscosity of the BGE above 233 
the sample zone. This pre-concentration strategy, named large volume sample stacking 234 
(LVSS), enhanced the sensitivity up to 100 times (in the nM range). The same pre-235 
concentration methodology, using glycerol instead of PDDCA to increase the viscosity 236 
of the BGE above the sample zone, was employed for the simultaneous determination of 237 
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different cationic and anionic neuroactive compounds in urine samples from a healthy 238 
volunteer [34]. Nanoparticles have been demonstrated to play an important role to reduce 239 
sample matrix due to their high specific surface area, demonstrating another promising 240 
alternative in the sample treatment for the extraction of catecholamines [35]. This 241 
methodology along with a pre-concentration technique by LVSS was applied to 242 
determine NE and DA in human urine from healthy volunteers obtaining LODs in the nM 243 
range. On the other hand, a dispersive microextraction such as ultrasound-assisted 244 
emulsification microextraction in combination with an in-capillary pre-concentration 245 
system named pH-mediated sample stacking was investigated as a sample treatment prior 246 
CE-UV analysis for simultaneous determination of 5-HT in spiked urine from a healthy 247 
volunteer [36]. 248 
Another pre-concentration strategy known as field-amplified sample stacking 249 
(FASS) has been employed to enhance the sensitivity by means of injecting a sample with 250 
lower conductivity than the BGE [37, 38]. Note that due to the fact that the presence of 251 
salts from the sample of urine disrupt the stacking strategy, MISPE was used to retain the 252 
target analytes and discard not only salts but also other components present in the samples 253 
of spiked urine [38]. This methodology allowed the analysis of DA, 3-methoxytyramine 254 
(3-MT) and 5-HT at nanomolar concentrations in less than 8 min using hydroxypropyl-255 
β-CD (HP--CD) to improve the selectivity of the separation.  256 
On the one hand, MIP combined with SPME demonstrated to be a powerful tool 257 
for the sensitive quantitative determination of catecholamines without pre-concentration 258 
step in non-spiked urine and spiked-serum from healthy volunteers by CE-UV [39]. In 259 
this work, the MIP fiber was developed in-situ obtaining a flexible, homogeneous, highly 260 
cross-linked, and porous fiber. By means of a MMIP combined with SPE, catecholamines 261 
DA, 3-MT, normetanephrine (NM), NE, and EP could be rapidly analyzed in spiked urine 262 
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with acceptable sensitivity without a pre-concentration step [40]. Ultra-fast determination 263 
(in only 3 min) of 5-HT was, for the first time, carried out in human whole blood by 264 
means of the so-called reverse injection, in which the injection is performed by the short-265 
end of the capillary [41]. 266 
Finally, a chiral stationary phase (CSP) in a monolithic MIP column using (-)-NE 267 
as a template was employed to the enantioseparation of (±)-EP, (±)-NE, (±)-octopamine 268 
and (±)-synephrine along with the separation of DA and (-)-isoproterenol in urine from a 269 
healthy volunteer [42]. Authors found a loss in the chiral separation power of some of the 270 
studied compounds caused by the saltiness of the urine sample studied due to the use of 271 
filtration as the only sample treatment. 272 
 273 
2.3. CE with fluorescence detection 274 
Laser Induced Fluorescence (LIF) is the detection system of choice when 275 
determining neuroactive compounds in biological samples by CE due to its excellent 276 
sensitivity [43]. As seen in Table 2, LODs up to 10-13 M and in most of the cases below 277 
10-9 M are obtained, even without the need to employ pre-concentration techniques. 278 
Generally, a derivatization step is necessary since most of neuroactive compounds lack 279 
of fluorescence moieties. However, depending on the excitation wavelengths used in LIF 280 
detection, some groups of analytes such as indoleamines, catecholamines, or aromatic-281 
containing compounds can be selectively detected without a labeling procedure. Thus, 282 
indoleamines, catecholamines, other biogenic amines, and amino acids as Trp and Tyr 283 
were detected with high sensitivity (between 10-12 and 10-8 M) in human urine and serum 284 
[44, 45, 47] and in rat brain tissue [46]. Interestingly, Li et al. used citrate-capped gold 285 
nanoparticles to capture and extract thiol-containing molecules and nucleobases in human 286 
urine and serum from a healthy volunteer [44]. Huang et al. developed a dynamic coating 287 
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based on poly(L-lysine) and silica nanoparticles to obtain coated capillaries with higher 288 
efficiencies and a longer durability in the separation of DA, EP, 5-HT, other biogenic 289 
amines, and amino acids in human urine samples to study changes in the levels of 290 
different neuroactive compounds after drinking tea [45]. 291 
Derivatization reagents need to fulfill several requirements such as stability, 292 
minimal hydrolysis products, low reaction times and fitting in the excitation wavelengths 293 
of argon-ion laser (351 and 488 nm among others) because this is the most common used 294 
laser (see Table 3). A comparison between derivatization reagents (CFSE, FITC, and 295 
NBD-F) was performed by Wagner et al. for the determination of the primary excitatory 296 
neuroactive compounds Glu and Asp [48]. Although the best LOD was obtained with 297 
NBD-F, FITC was chosen based on the high stability obtained. In a later work, same 298 
authors applied the method to the determination of Asp and Glu in brain ECF of chicks. 299 
Authors found higher levels of these two amino acids when stimulated with potassium 300 
and also in stress conditions compared to basal levels [49]. 301 
FITC has been one of the most employed derivatization reagents, although several 302 
hydrolysis products are obtained and this derivatization procedure implies to be carried 303 
out overnight, in the dark and at room temperature. However, high temperatures during 304 
sample derivatization [67] or microwave-assisted methods [50] have been found to 305 
produce a drastic reduction in the reaction times of this derivatization reagent (a few 306 
minutes). Thus, the derivatization of some amino acids (Ala, Asp, Glu,  Gly, Ser and Tau) 307 
with FITC at high temperatures in several samples (plasma, red blood cells, urine, 308 
cultured cells, CSF, saliva, and vitreous humor) allowed reducing derivatization reaction 309 
times down to 20 min [67]. On the other hand, a microwave-assisted derivatization 310 
method was described by Liu et al. [50] for the determination of FITC derivatized 311 
catecholamines, and a significant reduction in the derivatization time to only 2 min was 312 
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achieved. In addition, an in-capillary pre-concentration technique (FASS) was employed 313 
to achieve higher sensitivities (in the picomolar range). Figure 1 shows the 314 
electropherograms of rat brain samples obtained in normal injection and FASS mode, 315 
demonstrating the ability of the CE-LIF method to successfully determine concentrations 316 
as low as 100 ngL-1 of catecholamines in rat brain. This CE–LIF method provided better 317 
detectability when compared to those reported on catecholamines determination. On the 318 
other hand, Diao et al. showed the possibility of using light-emitting diodes (LEDs) as a 319 
radiation source alternative to other common lasers to determine FITC derivatized 320 
catecholamines in urine from healthy volunteers. LEDs have the advantages of having a 321 
small size, long lifetime, stable output with less energy consumption, broad range of 322 
emission wavelengths (280–1300 nm) and to be easy to operate with [47], although 323 
applications in CE have been very scarce.  324 
Another strategy that can be used to improve the derivatization step is conducting 325 
the derivatization reaction directly in the capillary before separation. An in-capillary 326 
derivatization strategy with OPA was employed for the in vivo monitoring in rat brain 327 
tissues by on-line microdialysis of several amino acids (Asp, GABA, Glu, Gly, Ser, and 328 
Tau) as important neuroactive compounds, observing changes in their levels after ethanol 329 
administration [31] or depending on the sleep stage [32]. Denoroy et al. [51] developed a 330 
rapid in-capillary NDA derivatization strategy to determine amino acids in extracellular 331 
fluid samples. Although it requires the use of the toxic reagent cyanide to react, NDA has 332 
been commonly used in neuroactive compounds determination due to the fact that is not 333 
fluorescent itself and reacts rapidly to give stable fluorescent derivatives that can be 334 
excited using low-cost visible lasers. A NDA-based method was employed to derivatize 335 
Glu, GABA and carbamathione, a metabolite of the drug disulfiram used in alcohol abuse 336 
and cocaine addiction treatments. This method was interestingly applied to monitor in 337 
16 
 
ECF from rats the in vivo changes induced by this metabolite in GABA and Glu levels 338 
after the administration of disulfiram [52]. Although half-life of carbamathione in brain 339 
is around 5 min, changes in basal concentrations of GABA and Glu after drug 340 
administration persisted for more than 2 h. Authors state that carbamathione could 341 
produce more long-lived metabolites producing the changes in GABA and Glu levels. 342 
Another NDA-based method was employed to derivatize amino acids, catecholamines, 343 
and other biogenic amines and to monitor in rat brain ECF the in vivo changes induced 344 
after 3-mercaptopropionic acid administrations, a convulsing drug which is used to induce 345 
seizures what produces ischemic events [53].  346 
Other derivatization reagents are CSFE, employed for monitoring the changes of 347 
Glu and Asp in the periaqueductal gray matter of rats after been stimulated by formalin 348 
injection [54], DTAF employed for the detection of DA and NE in spiked human serum 349 
[55], and NBD used for the labelling of several amino acids in different samples [56, 57].  350 
All works with LIF detection described so far have used the CZE mode for carrying 351 
out the separation of the compounds of interest. However, in some cases, CZE does not 352 
provide enough resolving power for the simultaneous separation of several compounds 353 
or they cannot be separated from the matrix interfering compounds. For this reason, in 354 
order to improve the separation selectivity of these approaches, some additives are 355 
employed in the separation medium such as dextran [44], surfactants (below its critical 356 
micelle concentration), sodium dodecyl sulfate (SDS) [48,49,56,57] or lithium dodecyl 357 
sulfate (LDS) [53], as well as cyclodextrins (CDs) [31,32,56,57]. CDs are a group of 358 
chiral oligosaccharides known for their high separation power and variability allowing 359 
them to be, not only the most employed chiral selectors, but also to be useful additives 360 
employed to improve separation and resolution. An example of the capability of CDs to 361 
improve electrophoretic separations was shown by Shi et al. with the combination of β-362 
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CD and SDS as additives in the BGE to determine NBD-GABA [56]. They determined 363 
this labeled compound in a complex mixture of several amino acids from the head of 364 
houseflies and diamondback moths. The same combination of SDS and β-CD was 365 
selected by Casado et al. to avoid the overlapping of the signals corresponding to the 366 
much higher concentration of NBD-Gln compared to the levels of NBD-GABA in CSF 367 
samples (CSF Gln/GABA ratio=5000:1) [57]. 368 
Although CZE has been the mode of choice for LIF detection, the MEKC mode has 369 
been also widely used with LIF detection, unlike in UV detection. MEKC is an approach 370 
very promising and interesting to simultaneous monitoring multiple neuroactive 371 
compounds in different biological samples. Thus, a clear example of the excellent 372 
performance of the MEKC mode was showed by Zhang et al. who developed a MEKC 373 
methodology to separate 19 amino acids and 2 catecholamines labeled with BQCA in 374 
different samples (human plasma and rabbit vitreous humor [58], or HEK293 and PC12 375 
cells [27]) using SDS together with acetonitrile to increase the hydrophobicity of the BGE 376 
and prevent comigration of all amine derivatives formed in CZE. Note that, an increase 377 
in several amino acids levels in plasma was found when compared diabetic to healthy 378 
patients (Figure 2) [58]. On the other hand, hyperlipidemic patients showed higher levels 379 
of Glu, Ala, Leu, Phe, and Lys, and lower levels of Gly in plasma compared to healthy 380 
patients. In addition, rabbit vitreous humor samples helped to conclude that amino acids 381 
levels increased under intraocular hypertension, whereas that Tau levels decreased. In this 382 
way, authors demonstrated that Tau plays a role in the regulation of osmotic pressure in 383 
eyes.  384 
Other MEKC works include an article in which authors used methanol to modify 385 
the selectivity in the determination of SIFA-labeled amino acids in saliva and in CSF 386 
from healthy volunteers [59]. Besides adding an organic solvent, some authors have also 387 
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modified the nature of the salt of the surfactant and buffer (lithium instead of sodium) to 388 
monitor GABA and Gly, derivatized with NDA, in rat brain ECF after administration of 389 
the drug disulfiram [60]. Moreover, in another work authors changed the nature of the 390 
surfactant completely using the cationic surfactant cetyltrimethyl ammonium bromide 391 
(CTAB) to separate seven TMBB-Su-labeled amino acids and to monitor their levels to 392 
establish a comparison between normal mice and Alzheimer’s disease transgenic model 393 
mice [26]. As in CZE, the use of CDs together with organic solvents can be useful in 394 
MEKC to modify the selectivity of complex separations. Following this strategy, Li et al. 395 
employed a mixture of HP-β-CD and dimethyl-β-CD (DM-β-CD) to investigate the 396 
changes of fourteen DTAF-labeled amino acids in microdialysates during cerebral 397 
ischemia/reperfusion period [23].  398 
Another strategy devoted to perform the determination of neuroactive compounds 399 
with LIF detection is the CE mode named Micro-Emulsion Electro-Kinetic 400 
Chromatography (MEEKC). Lin et al. [61] demonstrated the suitability of this 401 
methodology for hydrophobic FITC-labeled amino acid that easily entered into the oil 402 
phase of the MEEKC system. Using an optimized microwave-assisted derivatization 403 
protocol with FITC, the method was applied to different samples, including rat brain.  404 
In other sense and as above mentioned, chirality plays an important role in 405 
neuroscience and thus, the enantiomeric separation of neuroactive molecules has been 406 
one of the goals of some studies applying CE with LIF detection. D/L-Ser has been the 407 
most studied chiral amino acid due to its demonstrated enantioselectivity in neuronal 408 
functions [21,62-64]. Lorenzo et al. [21, 62] developed two similar methodologies using 409 
the most widely used mode in chiral CE, the Electrokinetic Chromatography (EKC). This 410 
mode utilizes the experimental technique of CZE in combination with the principle of 411 
chromatography, so that its separation principle relies on the different partition of 412 
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enantiomers between the bulk solution and the chiral pseudo-phase (chiral selector). 413 
These methodologies used β-CD as chiral selector to enantioseparate several NBD-414 
labeled amino acids (including Ser enantiomers) in mice rat tissue and in diabetic children 415 
urine [62] or in plasma from bipolar disorder patients [21]. In the latter work, the amino 416 
acids levels between patients with bipolar disorder and depressed patients’ are discussed, 417 
and authors found around 2 µM of D-Ser in bipolar disease patients. Unlike the previous 418 
two studies, Li et al. used a new methodology in which, besides the chiral pseudo-phase 419 
(i.e., CDs), employed a second charged pseudo-phase non-chiral capable of interacting 420 
with analites such as a charged micelle in MEKC [63, 64]. By this strategy, several FITC-421 
labeled amino acids, including only the chiral separation of D/L-Ser, were studied in ECF 422 
of rat brain. The enantioseparation of Ser could be used to study the importance of its D-423 
enantiomer as a key neuromodulator after ischemia and reperfusion periods [63, 64]. In 424 
addition, chronic treatment with resveratrol decreases the release of Glu, Asp, and D-Ser 425 
in ischemia and reperfusion events, whereas increase levels of GABA, Gly and Tau [63].  426 
D/L-Asp and D/L-Glu have also been studied by EKC, using a mixture of two CDs 427 
as chiral pseudo-phase to enantioseparate these analytes derivatized with NBD [65]. This 428 
method was applied in chicks brain tissues observing the presence of 1-2 % of D-Asp of 429 
the total Asp content, in all the studied brain areas. 430 
Finally, Samakashvili et al. developed an EKC strategy based on -CD as chiral 431 
pseudo-phase and SDS as second non-chiral charged pseudo-phase to study the levels of 432 
several FITC-labeled amino acids (GABA, Gly, and 8 D/L-amino acids) in CSF samples 433 
related with different stages of Alzheimer’s disease [66]. They found that Alzheimer’s 434 
disease subjects had lower amounts of L-Arg, L-Lys, L-Glu and L-Asp, but GABA levels 435 
increased. However, no significant differences were found in the rest of the studied amino 436 
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acids, including D-Ser. Once again, the importance of changes in amino acids levels is 437 
highlighted as they can be used as biomarkers for diagnosing diseases. 438 
 439 
2.4. CE with other detection systems 440 
Other detection systems such as mass spectrometry (MS), electrochemical, 441 
conductometric and chemiluminiscence have also been employed in CE determination of 442 
neuroactive molecules (see Table 4).  443 
CE-MS systems have been very scarcely used in the determination of neuroactive 444 
compounds despite the fact that they facilitate their unequivocal identification in complex 445 
biological samples. The most employed analyzer has been time of flight (TOF) followed 446 
by the ion trap (IT) and a quadrupole (Q) coupled to a TOF (hybrid system called QTOF) 447 
while in all cases the ionization source was ESI coupled with a coaxial sheath-flow 448 
interface, as seen in Table 4. The determination of ACh, Him, DA, and 5-HT in the nM 449 
range was performed for the metabolomics profiling of R2 neuron and metacerebral 450 
single cells from Aplysia californica [25]. A CE-MS method with a QTOF analyzer has 451 
been recently developed to simultaneously determine possible changes in GABA, some 452 
biogenic amines, and their metabolites after administration of the psychostimulant drug 453 
methylphenidate to Drosophila fruit fly [68]. In this work, using MS/MS experiments, 454 
the selected neuroactive compounds and their metabolites were unequivocally identified, 455 
observing that tyramine (Tym), OP, and DA levels changed when methylphenidate was 456 
administrated. By means of urine metabolic profiles obtained by a developed CE-MS 457 
methodology, Zeng et al. investigated the effect of the worldwide known plastic 458 
manufacturer Bisphenol A (BPA) administrated to rats for 45 days [69]. Due to its 459 
hormone-like properties, BPA dosage produced alterations of Glu, GABA, NE, 460 
neuroactive compounds-related metabolites (Tyr, Him, Val, and Tau) and several 461 
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pathways (D-glutamine (Gln) and D-Glu metabolism, histidine (His) metabolism, (Phe), 462 
Tyr and Trp biosynthesis, among others).  463 
Although just five CE-MS works were described, two of them were focused on 464 
chiral separations, both using an IT as analyzer in the MS/MS mode. The simultaneous 465 
enantioseparation of chiral precursors of DA as L/D-Phe, L/D-Tyr, and L/D-DOPA was 466 
described employing sulfated β-CD as chiral pseudo-phase in EKC and a partial filling 467 
technique (PFT) to prevent the entry of non-volatile chiral selector to the ionization source 468 
[24]. As Figure 3 shows, this method was applied to their quantification in PC-12 cells, 469 
demonstrating the enantiospecific metabolism of DOPA in this neuronal model as these 470 
cells only metabolized L-enantiomer leaving the D-DOPA intact. Recently, a new EKC 471 
methodology has shown, for the first time, not only the simultaneous enantioseparation 472 
of chiral precursors of DA (L/D-Phe, L/D-Tyr, and L/D-DOPA), but also DA and its 473 
chiral metabolites (L/D-NE and L/D-EP), facilitating the study of the entire Phe-Tyr 474 
metabolic pathway in plasma and brain tissue of rat [70].   475 
The amperometric detection (AD) is the electrochemical detection mode most used 476 
in CE both in CZE and MEKC. Using a standard electrode of Cu, six amino acids were 477 
detected by AD in serum samples from healthy volunteers with LODs in the range of μM 478 
[71]. Interestingly, Zhou et al. developed a FASS methodology along with a boron doped 479 
diamond electrode to detect the metabolites of catecholamines IXS, homovanillic acid 480 
(HVA) and VMA in the presence of Trp, other catecholamines and indoleamines with a 481 
good detection sensitivity (in the nM range) [72]. In this work, a fused-silica capillary 482 
was coated with gold nanoparticles embedded in PDDAC allowing the migration of 483 
catecholamines and indoleamines against the EOF not interfering with the determination 484 
of IXS, VMA, HVA, and Trp. Authors state that this method could be used to study the 485 
ratio HVA/MVA in urine samples, which is employed in the diagnosis of Menkes disease. 486 
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Another CZE methodology was developed by Liu et al. [73] to study the effect of noise 487 
in the levels of catecholamines and 5-HT present in rat brain tissue. A high sensitivity 488 
was obtained (in the nM range) using multiwalled carbon nanotubes as electrode.  489 
A MEKC methodology with AD detection was developed to determine 24 biogenic 490 
amines and their metabolites in flies (Drosophila melanogaster) brain tissue [75], 491 
demonstrating the high-resolution capabilities of this CE mode. Only 6 of the 24 studied 492 
compounds are believed to be related to alcohol consumption, and these 6 compounds 493 
(DA, OP, salsolinol, norsalsolinol, N-acetyldopamine, and N-acetyloctopamine) were the 494 
only ones quantified in the analyzed samples. Same authors applied this methodology to 495 
micro-dissected brain regions of Drosophila melanogaster finding less levels of DA and 496 
DOPA (see Figure 4), among others, in white mutant flies compared to red-eyes types 497 
[74]. Some years after same authors compared the conventional dissection procedure with 498 
a novel treatment named drying-freeze, what makes it a faster process [28].  499 
Cyclic voltammetry detection (CVD), is another electrochemical detection mode 500 
used in CE which was reported by Fang et al. [76]. Interestingly, the quantification of 501 
neuroactive compounds in a single Drosophila larva brain was carried out by implanting 502 
a microelectrode in their intact CNS prior analysis. LODs in the nM range were achieved 503 
by means of FASS as in-capillary pre-concentration technique.  504 
Regarding the conductometric detection, the main advantage is that in this detection 505 
mode the detector response does not depend on the presence of chromophores, 506 
fluorophores or electroactive groups and, although the conductometric detection is 507 
usually associated with poor sensitivities, in some cases LODs values are comparable to 508 
those obtained by UV, LIF, MS, AD or CVD detection, as Table 4 shows. Moreover, the 509 
sensitivity of these methodologies can be enhanced using pre-concentration strategies. 510 
Thus, LVSS was employed to increase the sensitivity a capacitive coupled contactless 511 
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conductivity detection (C4D) system for the analysis of GABA, Gly, and Glu in micro-512 
dialysates of periaqueductal gray matter obtaining LODs in the range of nM, values 513 
totally comparable with those obtained with a CE-LIF system [77]. An increase in Gly 514 
and Glu levels and a decrease in GABA after carrageenan-induced hyperalgesia was 515 
observed using the developed methodology. After perioral administration of paracetamol 516 
in this treatment, a reduction of Gly levels, without affecting Glu and GABA, was 517 
produced.  518 
Chemiluminiscence detection (CLD) has been another system employed for 519 
neuroactive molecules determination, principally in the case of the catecholamines DA, 520 
EP, and NE, as it is shown in Table 4. The luminol-based chemiluminiscence is the 521 
system used in CZE methods with CLD [20,78-80]. Catecholamines generally enhance 522 
the chemiluminiscence resulted from the reaction between luminol and some metal 523 
complexes. Thus, in the case of Ag (III)-luminol complex, Xiangdong et al. developed a 524 
methodology which enabled to obtain LODs from 10-8 to 10-7 M for EP, NE and DA 525 
determination in urine from pheochromocytoma patients (patients who showed abnormal 526 
levels of catecholamines in urine) [20]. Lower LODs were obtained in the determination 527 
of DA and EP levels in human urine from healthy volunteers using, in this case, 528 
nanocrystals quantum dots in the CE buffer to catalyze the chemiluminiscence reaction 529 
between luminol and hydrogen peroxide [78]. Finally, diperiodatocuprate (III) was 530 
employed as a transition metal chelate at an unstable high oxidation state, to react with 531 
luminol in a basic media allowing to obtain comparable LODs in the determination of 532 
DA and EP levels in human urine [79, 80]. In this system, EP enhanced the 533 
chemiluminiscence reaction to produce a very strong signal and enabling the application 534 
of this methodology to study differences in EP levels in urine of smoker and nonsmoker 535 




2.5. Microchip Capillary Electrophoresis 538 
Microfluidic devices or microchip have been gaining broad interest as separation 539 
platforms in CE. As Table 5 shows, different detection systems have been chosen for the 540 
determination of neuroactive compounds. Shi et al. [81] made a comparison between the 541 
derivatization reagents FITC and OPA and discussed the possibility of using an Hg-lamp 542 
excitation for LIF detection which, although it lowered the sensitivity, it offered a broad 543 
spectral excitation source. LODs in the µM range were obtained for several OPA-labeled 544 
amino acids determined in single human vascular endothelial (ECV-304) cells using a 545 
CZE mode where β-CD and a certain percentage of acetonitrile were necessary to improve 546 
the separation efficiency, obtaining an acceptable resolution in just 200 seconds. 547 
On the other hand, Li and Martin developed a strategy with LIF detection to 548 
quantify the amount of catecholamines released from PC-12 cells immobilized within the 549 
same microfluidic device [82]. This strategy allowed immobilized cells to be stimulated 550 
on-chip, and then, the released compounds were injected into the microchip where they 551 
were separated and then post-column derivatizated with NDA to be finally detected by 552 
LIF. LODs for the analytes of interest, DA and NE, were 70, and 250 µM, respectively.  553 
Amperometric detection (AD) has also been applied in microchip CE [83-85]. Wu 554 
et al. developed a dual-asymmetry electrokinetic flow focusing applied in-microchip for 555 
the pre-concentration of DA in spiked PC-12 cells obtaining LODs in the nM level [83]. 556 
This strategy was also applied by the same authors for the determination of DA and NE, 557 
in PC-12 cells of cerebral infarction and intracranial infection patients [84]. Zhao et al. 558 
[85] developed another application with AD to determine 5-HT, DA, and EP in spiked 559 
CSF from healthy human using a microfluidic PDMS device with its microchannel coated 560 
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with polystyrene nanosphere/polystyrene sulphonate to increase the separation efficiency 561 
and to stabilize the EOF. 562 
CLD has been used in microfluidic devices for the determination of biogenic 563 
amines including EP, DA, His, Tym, and agmatine in human urine samples from healthy 564 
volunteers [86]. In order to achieve a high sensitivity, a derivatization of the analytes with 565 
N-(4-aminobutyl)-N-ethylisoluminol (ABEI) previous the separation was carried out. 566 
LODs in the nM range were obtained using chemiluminiscence emission produced by the 567 
ABEI-tagged analytes, which reacted with hydrogen peroxide in the presence of the 568 
enzyme horseradish peroxidase. 569 
Recently, Li et al. employed a microchip platform coupled with MS detection using 570 
a nano-ESI interface and a IT analyzer for neuroactive molecules determination [87, 88]. 571 
In the first work, several amino acids were baseline separated in a glass/PDMS hybrid 572 
microchip in less than 120 seconds [87]. The developed systems obtained interesting 573 
LODs in the µM range and allowed to demonstrate the cellular release of these excitatory 574 
amino acids from PC-12 nerve cells incubated with ethanol. Likewise, the second paper 575 
describes the enantioselective metabolism of SH-SY5Y cells (cells often employed to 576 
study Parkinson’s disease) [88]. Authors observed how human SH-SY5Y neuronal cells 577 
only metabolized L-DOPA and left the D-enantiomer intact as it was observed in a 578 
previous work for PC-12 cells [24]. 579 
One of the advantages of microfluidic devices is its ease to be coupled to several 580 
sampling systems. Thus, a PDMS based microfluidic system for on-line coupling of 581 
microdialysis sampling to microchip in CE-LIF was described for in vivo determination 582 
of amino acids as neuroactive compounds in rat brain samples [89]. Although further 583 
studies and some modification should be considered, the described system shows a great 584 
potential in the deal of continuously monitoring the levels of neuroactive molecules. In 585 
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this sense it is necessary to consider that the development of a microchip system may also 586 
offer the possibility of creating a micro-total analysis system (µ-TAS). Cakal et al. [90] 587 
developed the first µ-TAS application for the determination of the catecholamines DA, 588 
EP, and NE where pre-concentration, separation, and detection steps were carried out on 589 
a single microchip. Monolithic disks were employed as SPE to purificate and pre-590 
concentrate the analytes which were detected in a standard solution after the elution and 591 
the electrophoretic separation by LIF. 592 
 593 
3.  Conclusions and future trends  594 
Research in neuroscience requires the determination of potential neuroactive 595 
molecules in biological matrices related with the nervous system. When analyzing 596 
biological samples with effective methodologies the knowledge of the CNS can be further 597 
explored. Among all the biological samples related to neuroscience, CSF, ECF, and brain 598 
tissue are the most straightforward samples for studying biochemical changes in the CNS 599 
due to the fact that they are in direct contact with the extracellular space of the brain. 600 
Nevertheless, the invasiveness of these samples, especially in the case of brain tissue, is 601 
remarkable. CSF and ECF are obtained by lumbar puncture or microdialysis, whereas 602 
brain tissue sampling can be only performed in post-mortem brain tissue from human or 603 
from model animals. These reasons make translational research a future trend, understood 604 
as the transferring of information obtained in the laboratory to the patients [91]. In this 605 
aspect, information obtained through analytical methodologies by the analysis of blood 606 
or urine can be easily extrapolated from model animals to human as these are translational 607 
samples. 608 
From all the CE methodologies described in this review it is worth highlighting the 609 
use of MEKC with LIF detection. In recent years, MEKC has demonstrated to be capable 610 
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of simultaneously monitor a great number of neuroactive substances offering a higher 611 
resolving power than the most CE mode employed, CZE. Meanwhile, LIF detection has 612 
proven to be the most sensitive of all the ones herein described, reaching LODs in the 613 
picomolar range, i.e. about 1000 times lower than other detection systems which 614 
generally achieve values in the nanomolar range. However, it is well known that LIF is a 615 
detection system with many drawbacks derived from the necessary derivatization 616 
reaction. Some of these drawbacks involve tortuous derivatization processes, high-cost 617 
derivatization reagents, and large fluorescence backgrounds when detecting low 618 
concentrated analytes. Therefore, avoiding the derivatization reaction is desirable to avoid 619 
the problems derived, situation that could be accomplished when the analytes present 620 
native fluorescence. An alternative to LIF detection is MS detection due to its ability to 621 
provide the unambiguous identification of analytes as well as for its capability to avoid 622 
interfering compounds present in biological samples. Still, one of the main limitations of 623 
the CE-MS system is the inconvenient raised from the coupling with a MEKC system, 624 
given the non-volatility of the surfactants commonly used in this separation mode. This 625 
is reflected by the fact that none of the applications described in the studied period of time 626 
used MEKC as separation mode.  627 
Note that the conclusions outlined above are perfectly reflected in a very recent 628 
research article published in the journal Nature, in which three different CE methods, CE-629 
LIF for labeled-molecules, CE-LIF for molecules with native fluorescence, and CE-MS 630 
were applied to detect and determine the concentration of several neuroactive compounds 631 
in ctenophores, a marine invertebrate with complex nervous and muscular systems, with 632 
the aim to demonstrate how ctenophore neural systems have evolved independently from 633 
those in other animals [92]. The methods described were used to study a broad range of 634 
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amino acids and other neuroactive molecules, including the L- and D- enantiomers of Glu 635 
and Asp, and enabled to obtain LODs in the range of nanomolar. 636 
Indeed, the importance of multiple and simultaneous detection of several analytes 637 
is an interesting feature in neuroscience since the alteration of more than one neuroactive 638 
substance at a time can be studied as a result of a stimulus or a disruption in a metabolomic 639 
pathway. Understanding chirality of neuroactive molecules is essential to increase the 640 
knowledge of the enantioselectivity of neurobiological and neurotransmission processes. 641 
However, information about D-amino acids in biological samples is not yet completed 642 
and thus, more work is required on this research aspect. Likewise, on-line coupling of 643 
sampling techniques followed by CE separation is one of the main promising trends in 644 
the analysis of biological samples, acquiring high relevance the microdialysis sampling. 645 
In another sense, further advances in methodologies to better harmonize the coupling of 646 
MS to the CE, especially in its MEKC mode as well as in applications of chiral separations 647 
for neuroscience studies are still required. Finally, building a comprehensive map of 648 
neuroactive compounds distribution and elucidating better models of neurotransmission 649 
is of remarkable importance. Therefore, a better understanding of the regulatory functions 650 
of neuroactive molecules will provide an increase of the knowledge of neurodegenerative 651 
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Figure captions  
 
Figure 1. Electropherograms showing the determination of catecholamines in rat brain 945 
sample spiked or non-spiked in normal injection mode (A) or FASS mode (B) by CZE-946 
LIF. Peaks: E: epinephrine; NE: norepinephrine; DA: dopamine. Experimental 947 
conditions: BGE: 50 mM boric acid with 40 mM borax (pH 8.9); voltage: 20 kV; 948 
temperature: 25 ºC; 40 x 50 µm i.d. uncoated fused-silica capillary; in (A) hydrodynamic 949 
injection: 0.5 psi for 3 s; in (B) electrokinetic injection: -5 kV for 25 s. Reproduced with 950 
permission from [50]. 951 
Figure 2. Electropherograms showing the separation of several amino acids and 952 
catecholamines by a MEKC-LIF method in plasma of a healthy person (A), plasma of a 953 
diabetes patient (B), plasma of a hyperlipidemia patient (C) and plasma of a 954 
hyperlipidemia patient spiked with 2 x 10-7 M of standard amino acids (except for Leu 955 
1x10-7  M, NE, and DA 2x10-6  M).  Peaks: 1, Asn; 2, His, Met, and Gln; 3, Ser; 4,Thr; 5 956 
Tyr; 6, Gly; 7, Glu; 8, Asp; 9, Ala; 10, Tau; 11, GABA; 12, NE; 13, Val; 14, DA; 15, Ile; 957 
16, Leu; 17, Phe; 18, Arg; 19, Lys. Experimental conditions: BGE: 120 mM boric acid 958 
(pH 9.1), 38.5 mM SDS, 19 % (v/v) ACN; voltage: 22.5 kV; temperature: 25 ºC; 60.2 cm 959 
x 75 µm i.d. uncoated fused-silica capillary; hydrodynamic injection: 0.5 psi for 5 s. 960 
Reproduced with permission from [58]. 961 
Figure 3. CE-MS/MS electropherograms obtained in the study of the DOPA metabolism 962 
in PC-12 cells: (A) racemic DOPA standard solution (50 µM for each enantiomer); (B) 963 
500 µM racemic DOPA incubated with the culture medium for 2 h; (C) 500 µM racemic 964 
DOPA incubated with PC-12 cells (2 x 106 cells/ml) for 2 h. Experimental conditions: 965 
BGE: 200 mM formic acid; PFT: 100 mbar for 50 s of 5 mM sulfated β-CD in BGE; 966 
43 
 
voltage: 30 kV; temperature: 20 ºC; 80 cm x 75 µm i.d. uncoated fused-silica capillary; 967 
hydrodynamic injection: 50 mbar for 12 s. Reproduced with permission from [24].  968 
Figure 4. MEKC-AD electropherograms obtained from dissected Drosophila brain 969 
homogenates for (A) wild-type, (B) white mutant and (C) TH-GFP mutant flies. Peaks 970 
correspond to DA (1), salsolinol (2), OP (3), N-acetyltyramine (4), N-acetylserotonin (5), 971 
N-acetyldopamine (6), L-DOPA (7), and the internal standard catechol (8). Experimental 972 
conditions: BGE: 25 mM borate (pH 9.7), 50 mM SDS, 2 % isopropranol; voltage: 15 973 
kV; temperature: not specified; 45 cm x 14 µm i.d. uncoated fused-silica capillary; 974 
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with acetonitrile  
CZE 
BGE: 5 mM formic acid (pH 4.0) and 1.2 % PDDAC 
Hydrostatic injection: 20 cm for 180 s  
60 cm x 75 µm, i.d. PDDAC coated capillary 
Temperature: not specified. Voltage: -15 kV 
220 nm LVSS 






, 5-HIAA, 5-HT, 
catechol, DA, DOPA, 




with acetonitrile  
CZE 
BGE: 500 mM Tris-borate (pH 9) and 10 % glycerol 
Hydrostatic injection: 25 cm for 180 s 
60 cm x 75 µm, i.d. PEO coated capillary 
Temperature: not specified. Voltage: 18 kV 
220 nm LVSS 
10 – 300 
x 10-9 
[34] 





BGE: 5 mM formic acid (pH 4.0) with 1.2 % PDDAC 
Hydrostatic injection: 20 cm x 120 s  
60 cm x 75 µm i.d. PDDAC coated capillary 
Temperature: not specified. Voltage: -15 kV 









BGE: 80 mM Tris-phosphate (pH 2.85) 
Hydrodynamic injection: 0.5 psi for 20 s  
58 cm x 75 µm i.d. uncoated fused-silica capillary 

























BGE: a pH 6.5 mixture of 20 mM MES and 30 mM 
phosphate buffer, 0.05 % hydroxypropylcellulose and 10% 
(v/v) methanol 
Electrokinetic injection: 12 kV for 30 s  
100 cm x 75 µm i.d. cellulose coated fused-silica capillary 
Temperature: 25 ºC. Voltage: 30 kV 
210 nm FASS 
10 – 120  
x 10-9 
[37] 





BGE: 10 mM of HP-β-CD in 80 mM phosphate buffer (pH 
4.0) 
Electrokinetic injection: 3 kV for 60 s  
60.2 cm x 50 µm i.d. uncoated fused-silica capillary 
Temperature: 25 ºC. Voltage: 30 kV 
214 nm FASS 2 x 10-9 [38] 










BGE: 20 mM borate buffer (pH 9.0) 
Hydrostatic injection: 15 cm for 10 s  
55 cm x 75 µm i.d uncoated fused-silica capillary 
Temperature: not specified. Voltage: 14 kV 
210 nm - 5 x 10-9 [39] 






BGE: 20 mM phosphate-borate (pH 5.5) 
Hydrodynamic injection: 50 mbar for 5 s 
64 cm x 50 µm i.d. uncoated fused-silica capillary 
Temperature: 25 ºC. Voltage: 20 kV 
205 nm - 










BGE: 400 mM Tris phosphate (pH 3.25) 
Reverse hydrodynamic injection: 0.5 psi for 10 s  
40 cm x 75 µm i.d. uncoated fused-silica capillary 
Temperature: 20 ºC. Voltage: -14 kV 























BGE: 10 mM citrate buffer (pH 3.0), 40 mM SDS, and 
acetonitrile (2:2:1, v:v:v) 
Hydrostatic injection: 10 cm for 5 s 
Temperature: 30 ºC. Voltage: 10 kV 
70 cm x 75 µm i.d chiral monolithic MIP column 
210 nm - Not specified [42] 
 992 
Abbreviations: MES: 2-(morpholino)ethanesulfonic acid; PEO: poly(ethylene oxide); PDDAC: poly-diallyldimethylammonium chloride; HP-β-CD: hydroxypropyl-beta-cyclodextrin; SDS: 993 
sodium dodecyl sulfate; 3-MT: 3-methoxytyramine. 5-HIAA: 5-hydroxyindole-3acetic acid. 5-HT: serotonin. DA: dopamine. DOPA: 3,4-dihydroxyphenylalanine. EP: epinephrine. IXS: 3-indoxyl 994 
sulfate. NE: norepinephrine. NM: normetanephrine. OP: octopamine. TA: tryptamine. Trp: tryptophan. Tym: tyramine. VMA: vanillomandelic acid.  995 
 996 




Separation mode and conditions 
Derivatization 
reagent 








gold nanoparticles  
CZE 
BGE: 2 % (w/v) dextran sulfate 100 mM in tris-borate 
buffer (pH 9.0) 
Hydrostatic injection: 20 cm for 20 s  
Temperature: not specified. Voltage: 15 kV 




λexc=266 nm  4 – 400 x 10-12 [44] 
5-HIAA, 5-HT, 
DA, DOPA, EP, 
HVA, TA, Trp, 
VMA 
Human urine Centrifugation  
CZE 
BGE: 10 mM formic acid (pH 3.7) 
Electrokinetic injection: 1 kV for 10 s 
Temperature: room temperature. Voltage: 15 kV 
40 cm x 75 µm i.d. coated capillary with poly(L-










Separation mode and conditions 
Derivatization 
reagent 
Detection  LOD (M) Ref. 
5-HT, DA, EP, NE,  






BGE: 25 mM citric acid (pH 2.5) 
Hydrodynamic injection: 0.5 psi for 20 s 
Temperature: not specified. Voltage: 30 kV 






4 – 30 x 10-9 [46] 





BGE: 20 mM β-CD in 20 mM borate (pH 9.5) with 10 % 
(v/v) acetonitrile 
Hydrostatic injection: 20 cm for 10 s 
Temperature: room temperature. Voltage: 13 kV 
47 cm x 75 µm i.d. uncoated fused-silica capillary 
FITC LED 3-10 x 10-10 [47] 
Asp, Glu 
ECF  




BGE: 20 mM SDS in 100 mM borate buffer (pH 8.5) 
Hydrodynamic injection: 3447 Pa for 5 s 
Temperature: 25 ºC. Voltage: -9 kV 





3 x 10-9 [48, 49] 





BGE: 50 mM boric acid with 40 mM borax (pH 8.9) 
Electrokinetic injection: -5 kV for 25 s 
Temperature: not specified. Voltage: 20 kV 




1.4 – 1.8 x 10-13 [50] 
Asp, Gly, Glu, Leu 
ECF  




BGE: 75 mM sodium borate (pH 9.2) 
Electrokinetic injection: 5 kV for 2.5 s 
Temperature: 30 ºC. Voltage: 25 kV 











Separation mode and conditions 
Derivatization 
reagent 








BGE: 50 mM borate buffer (pH 9.6) 
Hydrodynamic injection: 0.5 psi for 5 s 
Temperature: not specified. Voltage: 27.5 kV 
75 cm x 50 µm i.d. uncoated fused-silica capillary 
NDA λexc=442 nm  6 - 15 x 10-9 [52] 
Glu, GABA, NE, 
DA, DOPAC, 5-
HIAA, HVA, 5-HT 
ECF  




BGE:  20 mM LDS in 22.5 mM lithium tetraborate 
buffer (pH 9.2) 
Hydrodynamic injection: not specified 
Temperature: not specified. Voltage: 21 kV 




Not specified [53] 
Asp, Glu 
ECF  




BGE: 25 mM borate with 120 mM boric acid (pH 8.5) 
Hydrodynamic injection: 0.5 psi for 5 s 
Temperature: 25 ºC. Voltage: 25 kV 












BGE: 20 mM borate buffer (pH 9.8) 
Hydrodynamic injection: 0.5 psi for 3 s 
Temperature: 25 ºC. Voltage: 15 kV 




3 – 6 x 10-9 [55] 
Ala, Arg, Asp, 
GABA, Glu, Gly, 












BGE: 5.3 mM β-CD and 10.4 mM SDS in 32 mM 
borate buffer (pH 9.2) 
Hydrodynamic injection: 0.5 psi for 3 s 
Temperature: 25 ºC. Voltage: 15 kV 










Separation mode and conditions 
Derivatization 
reagent 
Detection  LOD (M) Ref. 
GABA, Gln Human CSF Not reported 
CZE  
BGE: 8.5 mM β-CD and 10 mM SDS in 200 mM 
borate buffer (pH 10.0) 
Hydrodynamic injection: 0.7 psi for 12 s 
Temperature: 25 ºC. Voltage: 20 kV 




1.0 x 10-9 [57] 
Ala, Arg, Asn, Asp, 
DA, GABA, Glu, 
Gln, Gly, His, Ile, 
Leu, Lys, Met, NE, 










BGE: 38.5 mM SDS in 120 mM sodium borate  
(pH 9.1) with 19% (v/v) acetonitrile 
Hydrodynamic injection: 0.5 psi for 5 s 
Temperature: 25 ºC. Voltage: 22.5 kV 













Wash with PBS, 







Asp,  GABA, Gln, 







BGE: 100 mM SDS in 100 mM boric acid (pH 9.6) 
with 8 % (v/v) methanol 
Hydrodynamic injection: 0.5 psi for 5 s 
Temperature: 25 ºC. Voltage: 20 kV 










Separation mode and conditions 
Derivatization 
reagent 
Detection  LOD (M) Ref. 
DA, GABA, Glu 
ECF  




BGE: 25 mM LDS in 22.5 mM lithium tetraborate 
with 10% (v/v) methanol 
Hydrodynamic injection: 5 psi for 2 s 
Temperature: room temperature. Voltage: 15 kV 




5-10 x 10-9 [60] 
Ala, Asp, GABA, 









BGE: 5.5 mM CTAB in 70 mM phosphate buffer (pH 
4.0) with 20 % (v/v) acetonitrile 
Hydrodynamic injection: 3447 Pa for 5 s  
Temperature: 25 ºC. Voltage: -22.5 kV 




2 – 14 x 10-10 [26] 
Ala, Arg, Asn, Asp, 
GABA, Glu, Gln, 
Gly, Lys,  Phe, Pro 
Ser, Trp, Tau 
ECF  




BGE: 100 mM SDS, 5 mM HP-β-CD, 5 mM  DM-β-
CD in 15 mM borate (pH 9.0) with 4 % (v/v) 
isopropanol 
Injection not specified  
Temperature: 25 ºC. Voltage: 17.5 kV 




9 – 54 x 10-11 [23] 
His, Arg, Gln, Pro, 
Tyr, Asn, Thr, Ser, 
Ala, Val, Met, Gly, 
Ile, Leu, Phe, Trp, 





BGE:  2.16% SDS, 6% 1-butanol, 0.6% cyclohexane, 
and 87.4% 30 mM phosphate buffer (pH 6.0) 
Hydrodynamic injection: 0.5 psi for 3 s  
Temperature: not specified. Voltage: 20 kV 










Separation mode and conditions 
Derivatization 
reagent 
Detection  LOD (M) Ref. 
D/L-Ser, D/L-Ala, 
Asp, GABA, D/L-
Gln, D/L-Glu, Gly, 
His, D/L-Ile, D/L-
Leu, Met D/L-Orn, 
D/L-Phe, D/L-Pro, 









BGE: 12.5 mM β-CD in 90 mM borate buffer (pH 
10.2) 
Hydrodynamic injection: 0.5 psi for 10 s  
Temperature: 17 ºC. Voltage: 21 kV 













Ultrafiltration  4 – 40  x 10-8 [21] 
D/L-Ser, Ala, Arg, 
Asp, DA,  GABA, 
Gln, Glu, Gly, Leu, 
Lys, Phe, Tau, Trp  
ECF  





BGE: 17.5 mM HP-β-CD, 5 mM DM-β-CD and 70 
mM SDS in 15 mM borate (pH 10.2) with 5 % (v/v) 
methanol  
Hydrodynamic injection: 0.5 psi for 5 s  
Temperature: 25 ºC. Voltage: 22.5 kV 













BGE: 8 mM DM-β-CD and 5 mM HPA-β-CD in 100 
mM borate buffer (pH 8.0) 
Voltage: -24 kV 
Temperature: 25 ºC 
60 cm x 75 µm i.d. polyacrylamide-coated fused-silica 
capillary 












Separation mode and conditions 
Derivatization 
reagent 







Human CSF Ultrafiltration 
Chiral EKC 
BGE: 20 mM β-CD and 80 mM SDS in 100 mM 
tetraborate buffer (pH 10.0) 
Hydrodynamic injection: 0.5 psi for 3 s  
Temperature: 30 ºC. Voltage: 20 kV 




1 – 16 x 10-9 [66] 
 998 
Abbreviations: SDS: sodium dodecilsulfate; LDS, lithium dodecilsulfate; CTAB, cetyltrimethyl ammonium bromide; 5-HIAA: 5-hydroxyindole-3-acetic acid. 5-HT: serotonin. Ala: alanine. 999 
Arg: arginine. Asn: asparagine. Asp: aspartate. Cit: citruline. Cys: cysteine. DA: dopamine. DOPA: 3,4-dihydroxyphenylalanine. DOPAC, 3,4-dihydroxyphenylaceticacid. EP: epinephrine. 1000 
GABA: γ-aminobutyric acid. Gln: glutamine. Glu: glutamate. Gly: glycine. Him: histamine. His: histidine. HVA: homovanillic acid. Ile: isoleucine. IXS: 3-indoxyl sulfate. Leu: leucine. Lys: 1001 
lysine. Met: methionine. NE: norepinephrine. NM: normetanephrine. OP: octopamine. Orn: ornithine. Phe: phenylalanine. Pro: proline. Ser: serine. TA: tryptamine. Tau: taurine. Thr: threonine. 1002 
Trp: tryptophan. Tym: tyramine. Tyr: tyrosine. Val: valine. VMA: vanillomandelic acid.  1003 
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Table 3. Derivatizing reagents (sorted in alphabetical order of abbreviations) used in the determination of neuroactive compounds by CE with LIF 1004 
detection. 1005 
Abbreviation Full name 
Most commonly 

































455 465-495 Diode 























Separation mode and conditions Detection system LOD (M) Ref. 







and isolation of 
neurons 
CZE 
BGE: 1 % (v/v) formic acid 
Hydrostatic injection: 15 cm for 60 s  
Temperature: not specified. Voltage: 20 kV 
100 cm x 40 µm i.d. uncoated fused-silica capillary 
MS (TOF) 
ESI+ coaxial sheath-flow 
Sheath liquid: 50:50 (v/v) 
methanol/water with 0.1% 
(v/v) formic acid 
5 - 35 x 10-9 [25] 







in formic acid 
CZE 
BGE: 50 mM citric acid (pH 2.1) 
Hydrodynamic injection: 10 psi for 5 s  
Temperature: not specified. Voltage: 20 kV 
80 cm x 50  µm i.d. uncoated fused-silica capillary 
MS (QTOF) 
ESI+ coaxial sheath-flow 
Sheath liquid: 70:30 (v/v) 
isopropanol/water 
--- [68] 
Asn, GABA, Glu, 





with 5-kDa cutoff 
filters 
CZE 
BGE: not specified 
Injection: not specified  
Voltage: not specified. Temperature: 20 ºC. 
80 cm x 50  µm i.d. uncoated fused-silica capillary 
 
MS (TOF) 
ESI+ coaxial sheath-flow 
Sheath liquid: 50:50 (v/v) 

















BGE: 200 mM formic acid 
PFT: 5 mM sulfated β-CD in BGE at 100 mbar for 
50 s  
Hydrodynamic injection: 50 mbar for 12 s 
Temperature: 20 ºC. Voltage: 30 kV. 
80 cm x 75 µm i.d. uncoated fused-silica capillary 
MS (IT) 
ESI+ coaxial sheath-flow 
Sheath liquid: 50:50 (v/v) 
methanol/water with 0.1 % 
(v/v) formic acid 
5 x 10-7 [24] 
D/L-DOPA, D/L-







BGE: 2 M formic acid 
PFT: 180 mM M-β-CD and 40 Mm HP-β-CD in 2 
M formic acid at 1 bar for 2.5 min 
Hydrodynamic injection: 50 mbar for 250 s 
Temperature: 15 ºC. Voltage: 30 kV. 
120 cm x 50 µm i.d. uncoated fused-silica capillary 
MS (IT) 
ESI+ coaxial sheath-flow 
Sheath liquid: 50:50 (v/v) 
methanol/water with 0.1 % 
(v/v) formic acid 




in perchloric and 
ascorbic acids 
and EDTA 








BGE: 50 mM borate buffer (pH 9.2) 
Electrokinetic injection: 15 kV for 10 s 
Temperature: room temperature. Voltage: 15 kV 
65 cm x 25 µm i.d. uncoated fused-silica capillary 






Separation mode and conditions Detection system LOD (M) Ref. 








BGE: 50 mM Tris-phosphate buffer (pH 3.0) 
Electrokinetic injection: -10 kV for 5 s  
Voltage: -10 kV. Temperature: 25 ºC 
45 cm x 50 µm i.d. gold nanoparticles embedded in 
poly(diallyl dimethylammonium) chloride-coated 
fused-silica capillary 
AD 7 x 10-8 [72] 









BGE: 180 mM phosphate buffer (pH 5.8) 
Electrokinetic injection: 15 kV for 10 s 
Voltage: 15 kV. Temperature: 20 ºC 
70 cm x 25 µm i.d. uncoated fused-silica capillary 
AD 9 x 10-10 [73] 
3,4-
dihydroxymandelic 
acid, 3-MT, 5-HIAA, 
5-HT, ascorbic acid, 
OP, DA, DOPA, 
















with 3-kDa cutoff 
filters 
MEKC 
BGE: 50 mM SDS in 25 mM borate buffer (pH 9.7) 
with 2 % isopropanol 
Electrokinetic injection: 5 kV for 5 s  
Temperature: not specified. Voltage: 15 kV 










Separation mode and conditions Detection system LOD (M) Ref. 










with PCA and 
centrifugation 
MEKC 
BGE: 50 mM SDS in 25 mM borate buffer (pH 9.5) 
with 2 % isopropanol 
Electrokinetic injection: 5 kV for 5 s  
Temperature: not specified. Voltage: 15 kV 









with PCA and 
centrifugation 
CZE 
BGE: 200 mM phosphate buffer (pH 4.5) with 
1 mM tetraborate 
Electrokinetic injection: 5 kV for 15 s  
Temperature: not specified. Voltage: 15 kV 
39 cm x 11 µm i.d. uncoated fused-silica capillary 
CVD 6.5 x 10-10 [76] 





BGE: 4 M acetic acid (pH 1.9) 
Hydrodynamic injection: 50 mbar for 100 s 
Temperature: 25 ºC. Voltage: 25 kV 
43 cm x 50  µm i.d. INST-coated fused-silica 
capillary 
C4D 9 - 15 x 10-9 [77] 






BGE:0.2 mM Ag (III) with 1 mM luminol in 20 
mM borate buffer (pH 9.5)  
Hydrostatic injection: 20 cm for 10 s  
Temperature: not specified. Voltage: 15 kV 
54 cm x 50 µm i.d. uncoated fused-silica capillary 












BGE: 0.3 mM luminol with 0.6 mM CdTe quantum 
dots in 25 mM borate buffer (pH 9.8)  
Hydrostatic injection: 20 cm or 10 s  
Voltage: 14 kV. Temperature: not specified.  
50 cm x 75 µm i.d. uncoated fused-silica capillary 






BGE: 0.1 mM luminol with 0.1 mM 
diperiodatocuprate (III) in 2 mM phosphate buffer 
(pH 11.5)  
Hydrostatic injection: 12 cm for 15 s  
Temperature: not specified. Voltage: 12 kV 
75 cm x 75 µm i.d. uncoated fused-silica capillary 






with acetonitrile  
CZE 
BGE: 0.1 mM luminol with 0.1 mM 
diperiodatocuprate (III) in 2.5 mM phosphate buffer 
(pH 6.0) 
Hydrostatic injection: 10 cm for 15 s  
Temperature: not specified. Voltage: 12 kV 
50 cm x 75 µm i.d. uncoated fused-silica capillary 
CLD 4.5 x 10-9 [80] 
Abbreviations: 3-MT: 3-methoxytyramine. 5-HIAA: 5-hydroxyindole-3-acetic acid. 5-HT: serotonin. Ala: alanine. Asp: aspartate. DA: dopamine. DOPA: 3,4-dihydroxyphenylalanine. DOPAC, 1009 
3,4-dihydroxyphenylaceticacid. EP: epinephrine. GABA: γ-aminobutyric acid. Glu: glutamate. Gly: glycine. HVA: homovanillic acid. IXS: 3-indoxyl sulfate. NE: norepinephrine. OP: 1010 
octopamine. Ser: serine. Tau: taurine. Trp: tryptophan. Tym: tyramine. Tyr: tyrosine. VMA: vanillomandelic acid; 5-HT: serotonin. ACh: acetylcholine. Asn: asparagine. DA: dopamine. DOPA: 1011 
3,4-dihydroxyphenylalanine. GABA: γ-aminobutyric acid. Glu: glutamate. Him: histamine. NE: norepinephrine. OP: octopamine. Phe: phenylalanine. Tau: taurine. Tym: tyramine. Tyr: tyrosine. 1012 





Table 5. Applications of microchip CE to the determination of neurotransmitters or related compounds in biological samples. 1016 
Analytes Sample Sample treatment Separation conditions 
Detector 
system 
LOD (M) Ref. 











BGE: 10 mM β-CD and 20 % (v/v) ACN in 20 mM borate buffer 
(pH 9.0) 
Pyrex glass microchip 
Electrokinetic injection in unpinched mode: 1000 V for 20 s  
Separation channel: 76 mm long x 50 µm wide x 20 µm deep 
Voltage: 2500 V 
LIF 0.4 - 1 x 10-6 [81] 





BGE: 3 mM SDS in 25 mM borate (pH 9.5) 
PDMS microchip 
Injection not specified 
Separation channel: 12 mm long x 250 µm wide x 90 µm deep 
Voltage: 1500 V 








BGE: 5 mM HEPES (pH 7.2) 
Pyrex glass microchip 
Electrokinetic injection in unpinched mode: 100 V for 60 s  
Separation channel: 30 mm long x 50 µm wide x 0.5 µm deep 
Voltage: 100 V 
AD 1 - 3  x 10-9 [83] 





BGE: 10 mM HEPES (pH 7.5) 
PDMS microchip 
Electrokinetic injection in unpinched mode: 100 V for 60 s  
Separation channel: 30 mm long x 50 µm wide x 0.5 µm deep 
Voltage: 50 V 
AD 1 - 3  x 10-9 [84] 
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Analytes Sample Sample treatment Separation conditions 
Detector 
system 
LOD (M) Ref. 








BGE: acetate solution (pH 6.0) 
PDMS microchip 
Electrokinetic injection in unpinched mode: 200 V for 1 s  
Separation channel: 35 mm long x 50 µm wide x 18 µm deep 
Voltage: 1000 V 
AD 1 - 6 x 10-6 [85] 







BGE: 10 µM horseradish peroxidase and 25 mM SDS in 20 mM 
phosphate buffer (pH 10.0),  
PDMS microchip 
Electrokinetic injection in pinched mode (see protocol) for 15 s  
Separation channel: 70 mm long x 70 µm wide x 25 µm deep 
Voltage: 1800 V 
CLD 0.1 x 10-9 [86] 








BGE: 25 mM ammonium acetate/acetic acid buffer (pH 4.3) in 
methanol/water 1:1 
Glass/PDMS microchip 
Electrokinetic injection in gated mode (see protocol) for 15 s  
Separation channel: 35 mm long x 60 µm wide x 20 µm deep 
Voltage: 1550 V 





Cells harvested and 




BGE: 15 mM ammonium acetate buffer (pH 5.5)/methanol (1:1)  
PFT: 15 mM sulfated-β-CD in BGE 
Glass/PDMS microchip 
Electrokinetic injection in unpinched mode: 600 V for 15 s  
Separation channel: 40 mm long x 60 µm wide x 20 µm deep 
Voltage: 3850 V 
MS (IT) 4 x 10-8 [88] 
Abbreviations: 5-HT: serotonin. Ala: alanine. Arg: arginine. Asp: aspartate. DA: dopamine. DOPA: 3,4-dihydroxyphenylalanine. GABA: γ-aminobutyric acid. Gln: glutamine. Glu: glutamate. 1017 
Gly: glycine. Him: histamine. His: histidine. Lys: lysine. NE: norepinephrine. Phe: phenylalanine. Ser: serine. Tau: taurine. Trp: tryptophan. Tym: tyramine. Tyr: tyrosine. Val: valine.1018 
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 Figure 4. 1067 
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